{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:58:34Z","timestamp":1781326714245,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017948","name":"Chongqing Academy of Science and Technology","doi-asserted-by":"publisher","award":["2024jbky10004"],"award-info":[{"award-number":["2024jbky10004"]}],"id":[{"id":"10.13039\/100017948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104074"],"award-info":[{"award-number":["82104074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118406","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:40:59Z","timestamp":1764175259000},"page":"118406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis, and evaluation of mupirocin prodrugs restoring systemic efficacy against MRSA"],"prefix":"10.1016","volume":"303","author":[{"given":"Zhi","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linpu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5322-7300","authenticated-orcid":false,"given":"Yun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118406_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/med.1016","article-title":"Role of drug metabolism in drug discovery and development","volume":"21","author":"Kumar","year":"2001","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118406_bib2","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.apsb.2022.03.009","article-title":"Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development","volume":"12","author":"Lai","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.118406_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/AAC.27.4.495","article-title":"Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use","volume":"27","author":"Sutherland","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118406_bib4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1126\/science.adn1369","article-title":"Two codependent routes lead to high-level MRSA","volume":"386","author":"Adedeji-Olulana","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118406_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Christopher","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.118406_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial resistance in ESKAPE pathogens","volume":"33","author":"De Oliveira","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2025.118406_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.microb.2025.100405","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA) and antimicrobial resistance in Lebanon: a scoping review","volume":"7","author":"Hamwi","year":"2025","journal-title":"Microbe"},{"key":"10.1016\/j.ejmech.2025.118406_bib8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1185\/03007990903512057","article-title":"The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: Vancomycin and linezolid","volume":"26","author":"Gary","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejmech.2025.118406_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acsinfecdis.1c00367","article-title":"Emerging roles of glycopeptide antibiotics: moving beyond Gram-positive bacteria","volume":"8","author":"Acharya","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118406_bib10","doi-asserted-by":"crossref","first-page":"47387","DOI":"10.1074\/jbc.M109089200","article-title":"Structural basis for the recognition of isoleucyl-adenylate and an antibiotic, mupirocin, by isoleucyl-tRNA synthetase","volume":"276","author":"Nakama","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118406_bib11","doi-asserted-by":"crossref","first-page":"12003","DOI":"10.1021\/jacs.1c02622","article-title":"Inhibition of isoleucyl-tRNA synthetase by the hybrid antibiotic thiomarinol","volume":"143","author":"Johnson","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118406_bib12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0190-9622(90)70116-Y","article-title":"The clinical development of mupirocin","volume":"22","author":"Pappa","year":"1990","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejmech.2025.118406_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2165\/00003495-198632050-00002","article-title":"Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use","volume":"32","author":"Ward","year":"1986","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2025.118406_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1515\/ejnm-2016-0006","article-title":"Nano-mupirocin: enabling the parenteral activity of mupirocin","volume":"8","author":"Cern","year":"2016","journal-title":"Eur. J. Nanomedicine"},{"key":"10.1016\/j.ejmech.2025.118406_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jconrel.2019.11.007","article-title":"Liposomal mupirocin holds promise for systemic treatment of invasive Staphylococcus aureus infections","volume":"316","author":"Goldmann","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejmech.2025.118406_bib16","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3390\/pharmaceutics13122186","article-title":"Therapeutic potential of injectable nano-mupirocin liposomes for infections involving multidrug-resistant bacteria","volume":"13","author":"Cern","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2025.118406_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jconrel.2024.07.045","article-title":"Nano-mupirocin as tumor-targeted antibiotic: physicochemical, immunotoxicological and pharmacokinetic characterization, and effect on gut microbiome","volume":"373","author":"Cern","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejmech.2025.118406_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113702","article-title":"Pathogen-targeting biomineralized bacterial outer membrane vesicles for eradicating both intracellular and extracellular Staphylococcus aureus","volume":"382","author":"Yang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejmech.2025.118406_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.ejmech.2025.118406_bib20","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s44222-025-00321-6","article-title":"Polyethylene glycol immunogenicity in nanomedicine","volume":"3","author":"Chen","year":"2025","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.ejmech.2025.118406_bib21","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3390\/pharmaceutics14091940","article-title":"Microfluidic manufacture of lipid-based nanomedicines","volume":"14","author":"Osouli-Bostanabad","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2025.118406_bib22","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrd.2018.46","article-title":"The expanding role of prodrugs in contemporary drug design and development","volume":"17","author":"Rautio","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118406_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.drudis.2013.08.014","article-title":"Chemistry-enabled drug delivery (prodrugs): recent progress and challenges","volume":"19","author":"Clas","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.118406_bib24","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1039\/C7CS00521K","article-title":"Self-assembling prodrugs","volume":"46","author":"Cheetham","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2025.118406_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41573-024-00914-7","article-title":"The landscape of small-molecule prodrugs","volume":"23","author":"Fralish","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118406_bib26","doi-asserted-by":"crossref","first-page":"12369","DOI":"10.1021\/acs.jmedchem.5c00826","article-title":"Current and emerging prodrug strategies","volume":"68","author":"Brown","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118406_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/17460441.2019.1567487","article-title":"Successes, failures, and future prospects of prodrugs and their clinical impact","volume":"14","author":"Najjar","year":"2019","journal-title":"Expert. Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118406_bib28","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1021\/bc500357n","article-title":"Mild method for succinimide hydrolysis on ADCs: impact on ADC potency, stability, exposure, and efficacy","volume":"25","author":"Tumey","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejmech.2025.118406_bib29","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/jm0109513","article-title":"Structure-based design of novel potent nonpeptide thrombin inhibitors","volume":"45","author":"Hauel","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118406_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/03602538809049622","article-title":"The design and bioactivation of presystemically stable prodrugs","volume":"19","author":"Svensson","year":"1988","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejmech.2025.118406_bib31","article-title":"Drug repurposing by siderophore conjugation: synthesis and biological evaluation of siderophore-methotrexate conjugates as antibiotics","volume":"61","author":"Zhao","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.118406_bib32","doi-asserted-by":"crossref","first-page":"8040","DOI":"10.1021\/acs.jmedchem.2c00615","article-title":"Optimization of the natural product calothrixin a to discover novel dual topoisomerase I and II inhibitors with improved anticancer activity","volume":"65","author":"Yang","year":"2022","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:47:05Z","timestamp":1781326025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"alternative-id":["S0223523425011717"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118406","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and evaluation of mupirocin prodrugs restoring systemic efficacy against MRSA","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118406"}}